News Releases

Spectral MD win Best Technology award at the European Mediscience Awards LONDON, U.K AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound

Validation study to assess up to 200 adult subjects with participation from leading U.S. principal investigators LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more

LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that the Annual Report and Accounts are now available on

Seasoned marketing & commercialisation professional to help bolster commercialisation expertise LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate

All key operational milestones outlined at admission to AIM achieved in a transformational year for the Company LONDON, U.K. AND DALLAS, TX, U.S –  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and

LONDON, U.K AND DALLAS, TX, U.S  –  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that its full year results for the year ended 31

LONDON, U.K AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it has granted options (“Options”) over 2,175,000

Unaudited cash and loss for the year ahead of expectations Burn and Diabetic Foot Ulcer clinical studies and regulatory pathway on track LONDON, U.K AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical

LONDON, U.K AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, has been notified that on 10 January 2022, Gerald Beaney, a

LONDON, U.K. AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces the exercise of options by an employee of the Company.